Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DH1V | ISIN: US3743964062 | Ticker-Symbol: ZGV3
Tradegate
24.01.25
19:40 Uhr
1,892 Euro
+0,124
+7,01 %
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
GEVO INC Chart 1 Jahr
5-Tage-Chart
GEVO INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,7601,82025.01.
1,7461,80824.01.
GlobeNewswire (Europe)
793 Leser
Artikel bewerten:
(2)

Gevo, Inc.: Gevo Provides Renewable Natural Gas Production Update

Finanznachrichten News

ENGLEWOOD, Colo., July 15, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) announced today that its renewable natural gas ("RNG") business recently achieved record production levels.

"I am pleased that we achieved an annualized production rate of approximately 402,000 MMBtu in May, exceeding our previous record of approximately 401,000 MMBtu in March," said Staci Bogue-Buchholz, Vice President and General Manager of Gevo's RNG facilities. "These results show we have hit our stride from a production perspective, and I think we have room for further improvement too. The system is running well."

On June 21, 2024, our RNG production experienced a slight disruption due to a severe flooding event that impacted the Rock Valley, Iowa community. As a result of our mitigation efforts, we still achieved monthly RNG production of 29,082 MMBtu in June inclusive of planned downtime for maintenance, and the system has returned to its normal operational state. The company does not expect this to materially impact the annual production target of approximately 400,000 MMBtu.

Commenting on the rain and flooding in Rock Valley, Bogue-Buchholz said: "While Gevo was lucky, many of our neighbors and surrounding communities were not so fortunate. We are heartbroken for our community as they deal with this tremendous impact and are looking for opportunities to support recovery and resiliency from future flooding."

Gevo's RNG is produced by capturing methane biogas from manure digestors across three dairy farms in northwest Iowa. The biogas is then delivered by pipeline to a centrally located gas upgrading unit where it is brought to pipeline-quality RNG and injected into the local gas pipeline.

RNG is biogenic methane that substitutes for fossil-based methane, or "natural gas". The benefit of RNG from a process like Gevo's, which is made from renewable carbon and mitigates fugitive methane emissions during production, is that the overall mitigation of greenhouse gases is large. The resulting carbon negative RNG may be purchased and claimed in California and other low-carbon fuels markets to fuel compressed natural gas heavy duty vehicles.

Gevo is currently operating under a California Air Resources Board ("CARB") temporary pathway, which provides the RNG produced with a carbon intensity score of -150 gCO2e/MJ. Gevo has applied for, and expects to receive, a permanent score of -350 gCO2e/MJ, the timing of which is uncertain but is believed to occur by the end of 2024. It is estimated that receipt of the permanent score will approximately double the stand-alone non-GAAP cash EBITDA1 currently generated by Gevo's RNG business.

About Gevo
Gevo's mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel and diesel fuel, that when burned have potential to yield net-zero greenhouse gas emissions when measured across the full life cycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their life cycle). Gevo's products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo's technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo's ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that its proven, patented technology enabling the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low-carbon products such as gasoline components, jet fuel and diesel fuel yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.

Gevo believes that the Argonne National Laboratory GREET model is the best available standard of scientific-based measurement for life cycle inventory or LCI.

Learn more at Gevo's website: www.gevo.com

IR Contact
Eric Frey
Vice President of Finance & Strategy
IR@Gevo.com

1 Non-GAAP cash EBITDA is calculated by adding back depreciation and amortization and non-cash stock-based compensation to GAAP loss from operations.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.